Scandinavian Tobacco Group A/S
Scandinavian Tobacco Group A/S (STBGY) Financial Performance & Income Statement Overview
Analyze Scandinavian Tobacco Group A/S (STBGY) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Scandinavian Tobacco Group A/S (STBGY) Income Statement & Financial Overview
Analyze Scandinavian Tobacco Group A/S’s STBGY earnings with segmented quarterly and yearly financial statement figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $1.97B | $2.46B | $2.43B | $2.37B |
Cost of Revenue | $1.11B | $1.30B | $1.30B | $1.61B |
Gross Profit | $866.70M | $1.16B | $1.13B | $755.10M |
Gross Profit Ratio | $0.44 | $0.47 | $0.46 | $0.32 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $285.90M | $0.00 | $293.80M | $544.50M |
Operating Expenses | $672.10M | $1.16B | $1.13B | $544.50M |
Total Costs & Expenses | $1.78B | $2.46B | $1.99B | $1.80B |
Interest Income | $16.10M | $0.00 | $52.80M | $16.00M |
Interest Expense | $89.00M | $0.00 | $78.40M | $68.60M |
Depreciation & Amortization | $111.30M | $106.70M | $117.80M | $98.30M |
EBITDA | $267.20M | $393.60M | $579.20M | $564.70M |
EBITDA Ratio | $0.14 | $0.16 | $0.24 | $0.24 |
Operating Income | $194.60M | $0.00 | $441.50M | $564.70M |
Operating Income Ratio | $0.10 | $0.00 | $0.18 | $0.24 |
Other Income/Expenses (Net) | -$127.70M | $292.30M | -$58.50M | -$187.90M |
Income Before Tax | $66.90M | $292.30M | $383.00M | $376.80M |
Income Before Tax Ratio | $0.03 | $0.12 | $0.16 | $0.16 |
Income Tax Expense | $15.40M | $71.30M | $85.90M | $88.30M |
Net Income | $51.50M | $221.00M | $297.10M | $296.80M |
Net Income Ratio | $0.03 | $0.09 | $0.12 | $0.13 |
EPS | $0.70 | $2.80 | $3.70 | $3.60 |
Diluted EPS | $0.65 | $2.70 | $3.60 | $3.50 |
Weighted Avg Shares Outstanding | $73.57M | $78.93M | $80.30M | $82.44M |
Weighted Avg Shares Outstanding (Diluted) | $78.84M | $81.85M | $82.53M | $84.80M |
Over the last four quarters, Scandinavian Tobacco Group A/S achieved steady financial progress, growing revenue from $2.37B in Q2 2024 to $1.97B in Q1 2025. Gross profit stayed firm with margins at 44% in Q1 2025 versus 32% in Q2 2024. Operating income totaled $194.60M in Q1 2025, maintaining a 10% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $267.20M. Net income dropped to $51.50M, with EPS at $0.70. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan